News

SBC-102, which is under clinical trials, is a recombinant human lysosomal acid lipase enzyme responsible for the breakdown of cholesteryl esters and triglycerides. Synageva R&D CMO and head

The company had provided only non-GLP services focused on early stage research and discovery. Aragen Bioscience specializes in recombinant cell line and hybridoma development, cell culture and protein

Zyclara cream is indicated for the treatment of actinic keratosis (AK) on the face and scalp. Meda CEO Anders Lonner said Zyclara will strengthen Meda’s dermatology franchise in

Under the agreement, Evotec will use PhosphoScout platform for discovery of protein-phosphorylation’s that predict favorable dosage and efficacy of targeted cancer drugs in patients. Evotec’s PhosphoScout platform uses

Orient Europharma intends to team up with 6 other Taiwanese clinical centers for conducting the study, named as immunotherapy Multikine anti tumor treatments (IT-MATTERS), which is already ongoing

The lawsuit was filed in connection with the abbreviated new drug application (ANDA) for Budesonide Capsules, 3mg, a generic version of AstraZeneca’s Entocort EC capsules. The US District

MOS is a provider of solutions to medical practices throughout the US. Simmons will take care of the company’s finances, management, business development, operations, customer growth and general

PNP Pharmaceuticals operates 48,000 square foot manufacturing facility in Canada. Sucanon, an oral treatment for type-2 diabetes, is a member of a class of diabetic medications called insulin

Eisai discovered perampanel (E2007) is a AMPA receptor antagonist indicated as a treatment for partial-onset seizures linked with epilepsy. The company’s submission of the application was supported by